2022 annual financial data
Keros Therapeutics 2022 Net margin
Direct answer
Net margin was -523.4%.
Operating income was -114,790,000 USD and net income was -104,679,000 USD.
Operating cash flow was -70,062,000 USD.
Get free Keros Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 20,000,000 USD
- Operating income
- -114,790,000 USD
- Net income
- -104,679,000 USD
- Operating cash flow
- -70,062,000 USD